Notice: This company has been marked as potentially delisted and may not be actively trading. Yumanity Therapeutics (YMTX) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisCompetitorsInsider TradesTrends Yumanity Therapeutics (NASDAQ:YMTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.45%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)5Amount OfInsider Selling(Last 3 Years)$73,329.08 Get YMTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Yumanity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address YMTX Insider Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Yumanity Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2022Michael D WyzgaInsiderSell3,116$1.69$5,266.04 12/2/2022Richard PetersCEOSell10,890$1.69$18,404.10 7/5/2022Richard PetersCEOSell4,584$1.85$8,480.40 6/3/2022Devin Whittemore SmithSVPSell2,923$1.19$3,478.37 6/3/2022Marie EpsteinInsiderSell1,806$1.19$2,149.14 6/3/2022Richard PetersCEOSell10,206$1.19$12,145.14 3/28/2022Richard PetersCEOSell10,715$1.85$19,822.75 2/3/2022Paulash MohsenInsiderSell1,958$1.83$3,583.14 (Data available from 1/1/2013 forward) YMTX Insider Trading Activity - Frequently Asked Questions Who is on Yumanity Therapeutics's Insider Roster? The list of insiders at Yumanity Therapeutics includes Devin Whittemore Smith, Marie Epstein, Michael D Wyzga, Paulash Mohsen, and Richard Peters. Learn more on insiders at YMTX. What percentage of Yumanity Therapeutics stock is owned by insiders? 12.45% of Yumanity Therapeutics stock is owned by insiders. Learn more on YMTX's insider holdings. Which Yumanity Therapeutics insiders have been selling company stock? The following insiders have sold YMTX shares in the last 24 months: Michael D Wyzga ($5,266.04), and Richard Peters ($18,404.10). How much insider selling is happening at Yumanity Therapeutics? Insiders have sold a total of 14,006 Yumanity Therapeutics shares in the last 24 months for a total of $23,670.14 sold. More Insider Trading Tools from MarketBeat Related Companies Eyenovia Insider Trades Lipocine Insider Trades BioXcel Therapeutics Insider Trades Aligos Therapeutics Insider Trades ImmuCell Insider Trades BioVie Insider Trades Bright Green Insider Trades MiNK Therapeutics Insider Trades MIRA Pharmaceuticals Insider Trades Flora Growth Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors This page (NASDAQ:YMTX) was last updated on 11/7/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Yumanity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YMTX Stock Alerts